Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker.

hTERT expression and tumour characteristics in patients with solid tumours Although the median level of hTERT transcript for patients with stages III and IV was 8.1 (0.04–86.6) compared with 0.7 (0.4–41.8) for patients with stages I and II, this difference did not reach statistical significance ( P =0.71), probably because of the low number of patients with localised disease (142 in stages III and IV compared to 14 in stages I and II).

also in 111,027 other papers